Correlation Between RenovoRx and NeuroSense Therapeutics
Can any of the company-specific risk be diversified away by investing in both RenovoRx and NeuroSense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and NeuroSense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and NeuroSense Therapeutics Ltd, you can compare the effects of market volatilities on RenovoRx and NeuroSense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of NeuroSense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and NeuroSense Therapeutics.
Diversification Opportunities for RenovoRx and NeuroSense Therapeutics
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between RenovoRx and NeuroSense is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and NeuroSense Therapeutics Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuroSense Therapeutics and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with NeuroSense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuroSense Therapeutics has no effect on the direction of RenovoRx i.e., RenovoRx and NeuroSense Therapeutics go up and down completely randomly.
Pair Corralation between RenovoRx and NeuroSense Therapeutics
Given the investment horizon of 90 days RenovoRx is expected to generate 2.37 times less return on investment than NeuroSense Therapeutics. But when comparing it to its historical volatility, RenovoRx is 6.64 times less risky than NeuroSense Therapeutics. It trades about 0.37 of its potential returns per unit of risk. NeuroSense Therapeutics Ltd is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 17.00 in NeuroSense Therapeutics Ltd on August 29, 2024 and sell it today you would lose (2.00) from holding NeuroSense Therapeutics Ltd or give up 11.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 68.18% |
| Values | Daily Returns |
RenovoRx vs. NeuroSense Therapeutics Ltd
Performance |
| Timeline |
| RenovoRx |
| NeuroSense Therapeutics |
RenovoRx and NeuroSense Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RenovoRx and NeuroSense Therapeutics
The main advantage of trading using opposite RenovoRx and NeuroSense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, NeuroSense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroSense Therapeutics will offset losses from the drop in NeuroSense Therapeutics' long position.| RenovoRx vs. Eliem Therapeutics | RenovoRx vs. Scpharmaceuticals | RenovoRx vs. Milestone Pharmaceuticals | RenovoRx vs. Seres Therapeutics |
| NeuroSense Therapeutics vs. Eliem Therapeutics | NeuroSense Therapeutics vs. Scpharmaceuticals | NeuroSense Therapeutics vs. Milestone Pharmaceuticals | NeuroSense Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |